Home page > OLD Wealth and Equity | Pharmaceuticals and Medical Devices | WTO Cancun Ministerial, September 2003 | Quality health systems and services | Medicines, health technology and health information | Irish Presidency priorities

Pharmaceuticals and Medicines


Please find all related articles below.



[Press release] A win for transparency: EPHA calls for TTIP negotiating documents to be opened to public scrutiny


4 July, Brussels – Yesterday the European Court of Justice ruled (1) that access to documents relating to international activity would not be automatically exempt from EU transparency requirements. This decision opens the possibility for the European Commission to make public papers relating to the EU-US trade deal, the Transatlantic Trade and Investment Partnership (TTIP). EPHA welcomes the ruling and calls for the release of all TTIP documents into the public sphere and for the (...)
04/07/2014

[Open letter] Europe + message to new European Parliament


Brussels, 1st of July 2014 - The European Parliament election results demonstrate a strong desire for change. From today you, as a new representative of the European people, have the opportunity to turn a new page, make daring political choices and propose institutional changes that will bring the EU closer to its citizens. If you don’t act now, others will take the opportunity to intigate negative reform. To the Members of the European Parliament Successive EU treaties have (...)
01/07/2014

[Joint press statement] The European Commission must not trade off our crown jewels when negotiating the EU-US trade and investment deal


17 June 2014, Brussels – Today, the Social Platform together with SOLIDAR, the European Federation of Public Services Union (EPSU) and the European Public Health Alliance (EPHA) organised a debate on the ‘possible impacts of the Transatlantic Trade and Investment Partnership (TTIP) on social and health services’ (1). During the discussion, it became clear that the TTIP could have a detrimental impact on essential public services such as social and health services. (...)
18/06/2014

[EPHA Report] The sixty-seventh World Health Assembly (WHA)


From 19 to 24 May 2014, the Sixty-seventh session of the World Health Assembly (WHA) took place in Geneva. The WHA is the supreme decision-making body of World Health Organization (WHO). It determines the policies of the WHO, appoints its Director-General, supervises the organisation’s financial policies, and reviews and approves the proposed programme budget. The WHA is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the (...)
06/06/2014

Medicines shortages in Europe: A disconcerting operational and communication challenge


The issue of medicine supply shortages has been highlighted by EPHA and its members throughout 2013, and it once again took centre stage at a recent workshop organised by the European Association of Hospital Pharmacists (EAHP). Already in winter, a common position on the issue has been drafted by members of the European Medicine Agency’s Patients’ and Consumers’ / Healthcare Professionals Working Party. 2014 EAHP Congress, Barcelona The 19th annual EAHP (...)
24/05/2014

[European Association of Hospital Pharmacists (EAHP)] Press Statement: Patients and professionals agree the future vision for hospital pharmacy in Europe


16 May 2014 - A robust set of hospital pharmacy practice standards for Europe has been agreed at an international Summit in Brussels. These standards should be met across European health systems to ensure safe, effective and optimal use of medicines in collaboration with multi-disciplinary teams. The standards, comprising 44 statements of practice, were agreed at the European Hospital Pharmacy Summit which concluded on Thursday 15th May, and was attended by more than 100 persons. The (...)
16/05/2014

[EU-US trade agreement] Investor-state dispute settlement (ISDS) consultation: A missed opportunity?


On 27 March, the European Commission (EC) launched a public consultation on the investor-state dispute settlement (ISDS) chapter within the context of the Transatlantic (ie EU-US) Trade and Investment Partnership (TTIP). Weeks earlier, the EU Trade Commissioner put a halt to negotiations over the ISDS due to mounting criticism from civil society groups and the European Parliament (EP). 07 April 2014 - This consultation has been presented by the EC as a solution to increase transparency (...)
07/04/2014

[Save the date] Patients’ Needs Driving Innovation in Global Health: March 10th, 2014


EPHA is organising a joint debate about the pivotal role that patients should play in creating innovative, affordable and quality technologies and products for poverty-related and neglected diseases. To register, please RSVP with your full name and contact details at anne.herrmann@dsw-brussels.org by March 6th.
24/02/2014

[EU-US trade agreement] Briefing for EPHA members


EPHA is creating a briefing for its members to understand the potential impacts of the TTIP on public health. To add items to the briefing, please contact the EPHA Secretariat at leonardo@epha.org. The document is intended to raise awareness among EPHA members (plus their members) and EPHA partners. The Transatlantic Trade and Investment Partnership (TTIP) is a trade and investment agreement that is currently being negotiated between the European Union (EU) and the United States (US). (...)
18/02/2014

EPHA news feed on the prospective EU-US Trade Agreement (TTIP) & its potential impact on public health - Subscribe!!


This week EPHA launched a weekly news feed about the latest developments around the prospective Transatlantic Trade and Investment Partnership (TTIP) – a free trade agreement currently being negotiated between the EU and the US and the potential negative effect it may have on public health outcomes on both sides of the Atlantic. To learn more about this topic, you can read: [EU-US trade agreement] Would it benefit Europe’s public health? This digest will primarily focus on (...)
16/01/2014